{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:32:42Z","timestamp":1790314362660,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100025230","name":"Biotest","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-026-08311-8","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:54:22Z","timestamp":1767966862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety of a cytomegalovirus-specific hyperimmunoglobulin in the prevention of maternal\u2013fetal transmission after primary infection\u2014results of an open-label, single-arm, prospective trial"],"prefix":"10.1007","volume":"313","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-5143","authenticated-orcid":false,"given":"Karl Oliver","family":"Kagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-074X","authenticated-orcid":false,"given":"Martin","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Oliver","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-8925","authenticated-orcid":false,"given":"Annegret","family":"Geipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"J\u00fcckstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8820-0116","authenticated-orcid":false,"given":"Jan-Peter","family":"Siedentopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Faschingbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitar Emilov","family":"Gechev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2375-3916","authenticated-orcid":false,"given":"Michael Robert","family":"Jaskolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-9092","authenticated-orcid":false,"given":"Irena","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Sch\u00fctze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Lentze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-7687","authenticated-orcid":false,"given":"Christiane","family":"Staiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"8311_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00404-017-4380-2","volume":"296","author":"KO Kagan","year":"2017","unstructured":"Kagan KO, Hamprecht K (2017) Cytomegalovirus infection in pregnancy. Arch Gynecol Obstet 296:15\u201326. https:\/\/doi.org\/10.1007\/s00404-017-4380-2","journal-title":"Arch Gynecol Obstet"},{"key":"8311_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal S, Emery VC, Lazzarotto T et al (2013) The \u201csilent\u201d global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86\u2013102. https:\/\/doi.org\/10.1128\/CMR.00062-12","journal-title":"Clin Microbiol Rev"},{"key":"8311_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","volume":"43","author":"C Marsico","year":"2017","unstructured":"Marsico C, Kimberlin DW (2017) Congenital cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr 43:38. https:\/\/doi.org\/10.1186\/s13052-017-0358-8","journal-title":"Ital J Pediatr"},{"issue":"8","key":"8311_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1159\/000518508","volume":"48","author":"R Devlieger","year":"2021","unstructured":"Devlieger R, Buxmann H, Nigro G et al (2021) Serial monitoring and hyperimmunoglobulin versus standard of care to prevent congenital cytomegalovirus infection: a phase III randomized trial. Fetal Diagn Ther 48(8):611\u2013623. https:\/\/doi.org\/10.1159\/000518508","journal-title":"Fetal Diagn Ther"},{"key":"8311_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1913569","volume":"385","author":"BL Hughes","year":"2021","unstructured":"Hughes BL, Clifton RG, Rouse DJ et al (2021) A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection. N Engl J Med 385:436\u2013444. https:\/\/doi.org\/10.1056\/NEJMoa1913569","journal-title":"N Engl J Med"},{"key":"8311_CR6","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/uog.23596","volume":"57","author":"KO Kagan","year":"2021","unstructured":"Kagan KO, Enders M, Hoopmann M et al (2021) Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study. Ultrasound Obstet Gynecol 57:560\u2013567. https:\/\/doi.org\/10.1002\/uog.23596","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8311_CR7","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJMoa043337","volume":"353","author":"G Nigro","year":"2005","unstructured":"Nigro G, Adler SP, La Torre R et al (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350\u20131362. https:\/\/doi.org\/10.1056\/NEJMoa043337","journal-title":"N Engl J Med"},{"key":"8311_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","volume":"370","author":"MG Revello","year":"2014","unstructured":"Revello MG, Lazzarotto T, Guerra B et al (2014) A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370:1316\u20131326. https:\/\/doi.org\/10.1056\/NEJMoa1310214","journal-title":"N Engl J Med"},{"key":"8311_CR9","doi-asserted-by":"publisher","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","volume":"40","author":"M Leruez-Ville","year":"2024","unstructured":"Leruez-Ville M, Chatzakis C, Lilleri D et al (2024) Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg Health Eur 40:100892. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100892","journal-title":"Lancet Reg Health Eur"},{"key":"8311_CR10","unstructured":"AWMF\u2014Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (2019) [Hypertensive pregnancy disorders: Diagnosis and therapy]. S2k-Leitlinie. Reg.-Nr. 015\/018: https:\/\/register.awmf.org\/assets\/guidelines\/015-18l_S2k_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2019-07.pdf"},{"key":"8311_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","volume":"223","author":"C Chatzakis","year":"2020","unstructured":"Chatzakis C, Ville Y, Makrydimas G et al (2020) Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol 223:870-883.e11. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.038","journal-title":"Am J Obstet Gynecol"},{"key":"8311_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1055\/s-0034-1385857","volume":"218","author":"M Voigt","year":"2014","unstructured":"Voigt M, Rochow N, Schneider KT et al (2014) New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007\u20132011 from all 16 states of Germany. Z Geburtshilfe Neonatol 218:210\u2013217. https:\/\/doi.org\/10.1055\/s-0034-1385857","journal-title":"Z Geburtshilfe Neonatol"},{"key":"8311_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/uog.19164","volume":"53","author":"KO Kagan","year":"2019","unstructured":"Kagan KO, Enders M, Schampera MS et al (2019) Prevention\u2009of\u2009maternal-fetal\u2009transmission\u2009of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration. Ultrasound Obstet Gynecol 53:383\u2013389. https:\/\/doi.org\/10.1002\/uog.19164","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8311_CR14","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMc1405377","volume":"370","author":"K Hamprecht","year":"2014","unstructured":"Hamprecht K, Kagan KO, Goelz R (2014) Hyperimmune globulin to prevent congenital CMV infection. N Engl J Med 370:2543. https:\/\/doi.org\/10.1056\/NEJMc1405377","journal-title":"N Engl J Med"},{"key":"8311_CR15","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/ijgo.15534","volume":"166","author":"MV Vasarri","year":"2024","unstructured":"Vasarri MV, Fernicola F, Arienti F et al (2024) Indirect impact of SARS-CoV-2 pandemic on incidence of maternal primary cytomegalovirus and Toxoplasma gondii infection in pregnancy. Int J Gynaecol Obstet 166:1218\u20131224. https:\/\/doi.org\/10.1002\/ijgo.15534","journal-title":"Int J Gynaecol Obstet"},{"key":"8311_CR16","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1056\/NEJMc23082","volume":"389","author":"BL Hughes","year":"2023","unstructured":"Hughes BL, Clifton RG, Rouse DJ et al (2023) Randomized trial of hyperimmune globulin for congenital CMV infection\u20142\u00a0year outcomes. N Engl J Med 389:1822\u20131824. https:\/\/doi.org\/10.1056\/NEJMc23082","journal-title":"N Engl J Med"},{"key":"8311_CR17","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ajog.2019.11.018","volume":"222","author":"GR Saade","year":"2020","unstructured":"Saade GR (2020) The effect of treatment of maternal CMV infection on the development of placental syndrome. Am J Obstet Gynecol 222:S2\u2013S3","journal-title":"Am J Obstet Gynecol"},{"key":"8311_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2025.04.014","author":"DJ Rouse","year":"2025","unstructured":"Rouse DJ, MacPherson C, Saade GR et al (2025) The association of cytomegalovirus hyperimmune globulin with adverse pregnancy outcomes. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2025.04.014","journal-title":"Am J Obstet Gynecol"},{"key":"8311_CR19","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/v16081241","volume":"16","author":"E Karofylakis","year":"2024","unstructured":"Karofylakis E, Thomas K, Kavatha D et al (2024) Cytomegalovirus-specific hyperimmune immunoglobulin administration for secondary prevention after first-trimester maternal primary infection: a 13-year single-center cohort study. Viruses 16:1241. https:\/\/doi.org\/10.3390\/v16081241","journal-title":"Viruses"},{"key":"8311_CR20","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.3390\/jcm12216776","volume":"12","author":"N Schirwani-Hartl","year":"2023","unstructured":"Schirwani-Hartl N, Palmrich P, Haberl C et al (2023) Biweekly versus monthly hyperimmune globulin therapy for primary cytomegalovirus infection in pregnancy. J Clin Med 12:6776. https:\/\/doi.org\/10.3390\/jcm12216776","journal-title":"J Clin Med"},{"key":"8311_CR21","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00404-020-05728-7","volume":"302","author":"V Seidel","year":"2020","unstructured":"Seidel V, Hackel\u00f6er M, Rancourt RC et al (2020) Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal\u2013fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis. Arch Gynecol Obstet 302:1353\u20131359. https:\/\/doi.org\/10.1007\/s00404-020-05728-7","journal-title":"Arch Gynecol Obstet"},{"key":"8311_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/cid\/ciz1030","volume":"71","author":"G Nigro","year":"2020","unstructured":"Nigro G, Adler SP (2020) High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection. Clin Infect Dis 71:1491\u20131498. https:\/\/doi.org\/10.1093\/cid\/ciz1030","journal-title":"Clin Infect Dis"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-026-08311-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-026-08311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:04:02Z","timestamp":1768165442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-026-08311-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8311"],"URL":"https:\/\/doi.org\/10.1007\/s00404-026-08311-8","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KOK is editor-in-chief of this journal and was coordinating investigator of the reported trial. ME was responsible for the laboratory analyses. MOS, AG, JJ, and JPS were principal investigators of further active sites. FF, IR, DG, were investigators, MRJ was co-investigator. JS, SA, SL and CS are employees of Biotest AG.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The appropriate trial-related documents were reviewed and approved by the competent local Independent Ethics Committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"24"}}